Sanofi announces subcutaneous Sarclisa Escena approved in U.S.
The U.S. Food and Drug Administration has approved subcutaneous Sarclisa Escena in combination with standard-of-care regimens for the treatment of patients with multiple myeloma across all existing indications of Sarclisa intravenous formulation, Sanofi announced. "With the approval, Sarclisa Escena is the first antica